Article info
Neuromuscular
Review
Rituximab in AChR subtype of myasthenia gravis: systematic review
- Correspondence to Dr Vincenzo Di Stefano, Department of Biomedicine, Neuroscience and advanced Diagnostic, University of Palermo, Palermo, Sicily, Italy; vincenzo19689{at}gmail.com
Citation
Rituximab in AChR subtype of myasthenia gravis: systematic review
Publication history
- Received December 10, 2019
- Revised February 4, 2020
- Accepted February 5, 2020
- First published February 25, 2020.
Online issue publication
March 17, 2020
Article Versions
- Previous version (16 March 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.